The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world genomics in metastatic urothelial carcinoma (mUC).
 
Sulin Wu
No Relationships to Disclose
 
Ravi Kumar Kyasaram
No Relationships to Disclose
 
Chen-Han Wilfred Wu
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Seunghee P. Margevicius
No Relationships to Disclose
 
Jorge A. Garcia
Honoraria - Aptitude Health; MJH Associates
Consulting or Advisory Role - Targeted Oncology
Research Funding - Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (I); Orion (Inst); Pfizer (Inst)
Other Relationship - FDA
 
Pedro C. Barata
Honoraria - UroToday
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Merck (Inst); Pfizer (Inst)
 
Prateek Mendiratta
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Seagen
Speakers' Bureau - Astellas Oncology; AstraZeneca; Seagen
 
Jason R Brown
Honoraria - AstraZeneca
Speakers' Bureau - EMD Serono
Research Funding - Bicycle Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novita Pharmaceuticals (Inst); Seagen (Inst)